[Federal Register: September 12, 2008 (Volume 73, Number 178)]
[Notices]
[Page 53003-53005]
[DOCID:fr12se08-58]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2008-0673; FRL-8382-8]

FIFRA Scientific Advisory Panel; Notice of Public Meeting

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: There will be a four-day meeting of the Federal Insecticide,
Fungicide, and Rodenticide Act Scientific Advisory Panel (FIFRA SAP) to
consider and review the Scientific Issues Associated with Worker
Reentry Exposure Assessment.

DATES: The meeting will be held on December 2-5, 2008, from
approximately 9:00 a.m. to 5:00 p.m, eastern time.
    Comments. The Agency encourages that written comments be submitted
by November 18, 2008 and requests for oral comments be submitted by
November 25, 2008. However, written comments and requests to make oral
comments may be submitted until the date of the meeting, but anyone
submitting written comments after November 18, 2008 should contact the
Designated Federal Official (DFO) listed under FOR FURTHER INFORMATION
CONTACT. For additional instructions, see Unit I.C. of the
SUPPLEMENTARY INFORMATION.
    Nominations. Nominations of candidates to serve as ad hoc members
of the FIFRA SAP for this meeting should be provided on or before
September 22, 2008.
    Special accommodations. For information on access or services for
individuals with disabilities, and to request accommodation of a
disability, please contact the DFO listed under FOR FURTHER INFORMATION
CONTACT at least 10 days prior to the meeting to give EPA as much time
as possible to process your request.

ADDRESSES: The meeting will be held at the Environmental Protection
Agency, Conference Center, Lobby Level, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA 22202.
    Comments. Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2008-0673, by one of the following methods:
      Federal eRulemaking Portal: http://www.regulations.gov.
Follow the on-line instructions for submitting comments.
      Mail: Office of Pesticide Programs (OPP) Regulatory
Public Docket (7502P), Environmental Protection Agency, 1200
Pennsylvania Ave., NW, Washington, DC 20460-0001.
     Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
accepted during the Docket Facility's normal hours of operation (8:30
a.m. to 4 p.m., Monday through Friday, excluding legal holidays).
Special arrangements should be made for deliveries of boxed
information. The Docket Facility telephone number is<PHONE_NUMBER>.
    Instructions. Direct your comments to docket ID number EPA-HQ-OPP-
2008-0673. If your comments contain any information that you consider
to be CBI or otherwise protected, please contact the DFO listed under
FOR FURTHER INFORMATION CONTACT to obtain special instructions before
submitting your comments. EPA's policy is that all comments received
will be included in the docket without change and may be made available
on-line at http://www.regulations.gov, including any personal
information provided, unless the comment includes information claimed
to be Confidential Business Information (CBI) or other information
whose disclosure is restricted by statute. Do not submit information
that you consider to be CBI or otherwise protected through
regulations.gov or e-mail. The regulations.gov website is an
``anonymous access'' system, which means EPA will not know your
identity or contact information unless you provide it in the body of
your comment. If you send an e-mail comment directly to EPA without
going through regulations.gov, your e-mail address will be
automatically captured and included as part of the comment that is
placed in the docket and made available on the Internet. If you submit
an electronic comment, EPA recommends that you include your name and
other contact information in the body of your comment and with any disk
or CD-ROM you submit. If EPA cannot read your comment due to technical
difficulties and cannot contact you for clarification, EPA may not be
able to consider your comment. Electronic files should avoid the use of
special characters, any form of encryption, and be free of any defects
or viruses.
    Docket: All documents in the docket are listed in the docket index
available at http://www.regulations.gov. Although listed in the index,
some information is not publicly available, e.g., CBI or other
information whose disclosure is restricted by statute. Certain other
material, such as copyrighted material, is not placed on the Internet
and will be publicly available only in hard copy form. Publicly
available docket materials are available either in the electronic
docket at http://www.regulations.gov, or, if only available in hard
copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac
Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The hours of
operation of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday
through Friday, excluding legal holidays. The Docket Facility telephone
number is<PHONE_NUMBER>.
    Nominations, requests to present oral comments, and requests for
special accommodations. Submit nominations to serve as ad hoc members
of the FIFRA SAP, requests for special seating accommodations, or
requests to present oral comments to the DFO listed under FOR FURTHER
INFORMATION CONTACT.

FOR FURTHER INFORMATION CONTACT: Jim Downing, DFO, Office of Science
Coordination and Policy (7201M), Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:
(202) 564-8432; fax number: (202) 564-

8382; e-mail addresses<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    This action is directed to the public in general. This action may,
however, be of interest to persons who are or may be required to
conduct testing of chemical substances under the Federal Food, Drug,
and Cosmetic Act (FFDCA), FIFRA, and the Food Quality Protection Act of
1996 (FQPA). Since other entities may also be interested, the Agency
has not attempted to describe all the specific entities that may be
affected by this action. If you have any questions regarding the
applicability of this action to a particular entity, consult the DFO
listed under FOR FURTHER INFORMATION CONTACT.

B. What Should I Consider as I Prepare My Comments for EPA?

    When submitting comments, remember to:
    1. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
     2. Follow directions. The Agency may ask you to respond to
specific questions or organize comments by referencing a Code of
Federal Regulations (CFR) part or section number.
    3. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
    4. Describe any assumptions and provide any technical information
and/or data that you used.
    5. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
    6. Provide specific examples to illustrate your concerns and
suggest alternatives.
    7. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
    8. Make sure to submit your comments by the comment period deadline
identified.

C. How May I Participate in this Meeting?

    You may participate in this meeting by following the instructions
in this unit. To ensure proper receipt by EPA, it is imperative that
you identify docket ID number EPA-HQ-OPP-2008-0673 in the subject line
on the first page of your request.
    1. Written comments. The Agency encourages that written comments be
submitted, using the instructions in ADDRESSES, no later than November
18, 2008, to provide FIFRA SAP the time necessary to consider and
review the written comments. Written comments are accepted until the
date of the meeting, but anyone submitting written comments after
November 18, 2008 should contact the DFO listed under FOR FURTHER
INFORMATION CONTACT. Anyone submitting written comments at the meeting
should bring 30 copies for distribution to the FIFRA SAP.
    2. Oral comments. The Agency encourages that each individual or
group wishing to make brief oral comments to FIFRA SAP submit their
request to the DFO listed under FOR FURTHER INFORMATION CONTACT no
later than November 25, 2008, in order to be included on the meeting
agenda. Requests to present oral comments will be accepted until the
date of the meeting and, to the extent that time permits, the Chair of
the FIFRA SAP may permit the presentation of oral comments at the
meeting by interested persons who have not previously requested time.
The request should identify the name of the individual making the
presentation, the organization (if any) the individual will represent,
and any requirements for audiovisual equipment (e.g., overhead
projector, 35 mm projector, chalkboard). Oral comments before FIFRA SAP
are limited to approximately 5 minutes unless prior arrangements have
been made. In addition, each speaker should bring 30 copies of his or
her comments and presentation slides for distribution to the FIFRA SAP
at the meeting.
    3. Seating at the meeting. Seating at the meeting will be open and
on a first-come basis.
    4. Request for nominations to serve as ad hoc members of the FIFRA
SAP for this meeting. As part of a broader process for developing a
pool of candidates for each meeting, the FIFRA SAP staff routinely
solicits the stakeholder community for nominations of prospective
candidates for service as ad hoc members of the FIFRA SAP. Any
interested person or organization may nominate qualified individuals to
be considered as prospective candidates for a specific meeting.
Individuals nominated for this meeting should have expertise in one or
more of the following areas: occupational pesticide exposure and risk
assessment, agronomy and agricultural production practices, statistics,
and labor statistics. Nominees should be scientists who have sufficient
professional qualifications, including training and experience, to be
capable of providing expert comments on the scientific issues for this
meeting. Nominees should be identified by name, occupation, position,
address, and telephone number. Nominations should be provided to the
DFO listed under FOR FURTHER INFORMATION CONTACT on or before September
22, 2008. The Agency will consider all nominations of prospective
candidates for this meeting that are received on or before this date.
However, final selection of ad hoc members for this meeting is a
discretionary function of the Agency.
    The selection of scientists to serve on the FIFRA SAP is based on
the function of the panel and the expertise needed to address the
Agency's charge to the panel. No interested scientists shall be
ineligible to serve by reason of their membership on any other advisory
committee to a Federal department or agency or their employment by a
Federal department or agency except the EPA. Other factors considered
during the selection process include availability of the potential
panel member to fully participate in the panel's reviews, absence of
any conflicts of interest or appearance of lack of impartiality,
independence with respect to the matters under review, and lack of
bias. Although financial conflicts of interest, the appearance of lack
of impartiality, lack of independence, and bias may result in
disqualification, the absence of such concerns does not assure that a
candidate will be selected to serve on the FIFRA SAP. Numerous
qualified candidates are identified for each panel. Therefore,
selection decisions involve carefully weighing a number of factors
including the candidates' areas of expertise and professional
qualifications and achieving an overall balance of different scientific
perspectives on the panel. In order to have the collective breadth of
experience needed to address the Agency's charge for this meeting, the
Agency anticipates selecting approximately 10 to 12 ad hoc scientists.
    FIFRA SAP members are subject to the provisions of 5 CFR part 2634,
Executive Branch Financial Disclosure, as supplemented by the EPA in 5
CFR part 6401. In anticipation of this requirement, prospective
candidates for service on the FIFRA SAP will be asked to submit
confidential financial information which shall fully disclose, among
other financial interests, the candidate's employment, stocks and
bonds, and where applicable, sources of research support. The EPA will
evaluate the candidates financial disclosure form to assess whether
there are financial conflicts of interest, appearance of a lack of
impartiality or any prior involvement with the development of the
documents under consideration (including previous scientific peer

review) before the candidate is considered further for service on the
FIFRA SAP. Those who are selected from the pool of prospective
candidates will be asked to attend the public meetings and to
participate in the discussion of key issues and assumptions at these
meetings. In addition, they will be asked to review and to help
finalize the meeting minutes. The list of FIFRA SAP members
participating at this meeting will be posted on the FIFRA SAP website
at http://epa.gov/scipoly/sap or may be obtained from the OPP
Regulatory Public Docket at http://www.regulations.gov.

II. Background

A. Purpose of the FIFRA SAP

    The FIFRA SAP serves as the primary scientific peer review
mechanism of EPA's Office of Prevention, Pesticides and Toxic
Substances (OPPTS) and is structured to provide scientific advice,
information and recommendations to the EPA Administrator on pesticides
and pesticide-related issues as to the impact of regulatory actions on
health and the environment. The FIFRA SAP is a Federal advisory
committee established in 1975 under FIFRA that operates in accordance
with requirements of the Federal Advisory Committee Act. The FIFRA SAP
is composed of a permanent panel consisting of seven members who are
appointed by the EPA Administrator from nominees provided by the
National Institutes of Health and the National Science Foundation.
FIFRA, as amended by FQPA, established a Science Review Board
consisting of at least 60 scientists who are available to the
Scientific Advisory Panel on an ad hoc basis to assist in reviews
conducted by the Scientific Advisory Panel. As a peer review mechanism,
the FIFRA SAP provides comments, evaluations and recommendations to
improve the effectiveness and quality of analyses made by Agency
scientists. Members of the FIFRA SAP are scientists who have sufficient
professional qualifications, including training and experience, to
provide expert advice and recommendation to the Agency.

B. Public Meeting

    Extensive investigation of hand labor activities in agriculture and
subsequent occupational, post-application exposure monitoring were
conducted as a result of an EPA data call-in (DCI) in 1995. An industry
task force, the Agricultural Reentry Task Force (ARTF), was formed to
produce the data to satisfy the data requirements. In conjunction with
the U.S Environmental Protection Agency (EPA), Health Canada's Pest
Management Regulatory Agency (PMRA), and the California Department of
Pesticide Regulation (CDPR), the Task Force proposed and conducted
exposure monitoring studies for field workers engaged in hand labor
activities in a variety of crops across agriculture.
    The data from the completed studies now comprise a generic database
for use in conducting occupational post-application exposure assessment
in all agricultural settings. Based on the types of crops and
activities monitored, the database is organized into crop-activity
groups, or clusters, designed to represent, and enable exposure
assessment of all hand labor activities that occur in agriculture.
    During this meeting of the FIFRA SAP, the Agency will provide an
overview of occupational post-application monitoring studies conducted
by the ARTF as well as the proposed organization, content, structure,
and characteristics of the database. The overview will contain
discussions of the criteria used to define the appropriate activities
to monitor, how crops and crop activities were grouped into clusters,
how the completed data are interpreted and used, and the general
methodology and assumptions underlying post-application exposure
assessments. Finally, the regulatory agencies will discuss the peer
review process that was followed in developing and making decisions on
the use of this database.
    The goal of this meeting is for the Agency to seek comments from
the FIFRA SAP on the adequacy of the data collected, the
appropriateness of the clustering decisions, the utility of the
database for occupational post-application exposure assessment in
agricultural settings, and some of the critical assumptions used in
estimating exposures.

C. FIFRA SAP Documents and Meeting Minutes

    EPA's background paper, related supporting materials, charge/
questions to the FIFRA SAP, FIFRA SAP composition (i.e., members and ad
hoc members for this meeting), and the meeting agenda will be available
by late November 2008. In addition, the Agency may provide additional
background documents as the materials become available. You may obtain
electronic copies of these documents, and certain other related
documents that might be available electronically, at http://
www.regulations.gov and the FIFRA SAP homepage at http://www.epa.gov/
scipoly/sap.
    The FIFRA SAP will prepare meeting minutes summarizing its
recommendations to the Agency approximately 90 days after the meeting.
The meeting minutes will be posted on the FIFRA SAP website or may be
obtained from the OPP Regulatory Public Docket at http://
www.regulations.gov.

List of Subjects

    Environmental protection, Pesticides and pests.

    Dated: September 4, 2008.
Elizabeth A. Resek,
Acting Director, Office of Science Coordination and Policy.
[FR Doc. E8-21147 Filed 9-11-08; 8:45 am]

BILLING CODE 6560-50-S


[Federal Register Volume 84, Number 173 (Friday, September 6, 2019)]
[Notices]
[Pages 47056-47057]
[FR Doc No: 2019-19261]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2019-0010]

Qualification of Drivers; Exemption Applications; Vision

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of final disposition.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces its decision to exempt ten individuals from
the vision requirement in the Federal Motor Carrier Safety Regulations
(FMCSRs) to operate a commercial motor vehicle (CMV) in interstate
commerce. They are unable to meet the vision requirement in one eye for
various reasons. The exemptions enable these individuals to operate
CMVs in interstate commerce without meeting the vision requirement in
one eye.

DATES: The exemptions were applicable on July 20, 2019. The exemptions
expire on July 20, 2021.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
ET, Monday through Friday, except Federal holidays. If you have
questions regarding viewing or submitting material to the docket,
contact Docket Services,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Public Participation

A. Viewing Documents and Comments

    To view comments, as well as any documents mentioned in this notice
as being available in the docket, go to http://www.regulations.gov/docket?D=FMCSA-2019-0010 and choose the document to review. If you do
not have access to the internet, you may view the docket online by
visiting the Docket Management Facility in Room W12-140 on the ground
floor of the DOT West Building, 1200 New Jersey Avenue SE, Washington,
DC 20590, between 9 a.m. and 5 p.m., ET, Monday through Friday, except
Federal holidays.

B. Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the
public to better inform its rulemaking process. DOT posts these
comments, without edit, including any personal information the
commenter provides, to www.regulations.gov, as described in the system
of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.

II. Background

    On June 19, 2019, FMCSA published a notice announcing receipt of
applications from ten individuals requesting an exemption from vision
requirement in 49 CFR 391.41(b)(10) and requested comments from the
public (84 FR 28619). The public comment period ended on July 19, 2019,
and one comment was received.
    FMCSA has evaluated the eligibility of these applicants and
determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to, or greater than, the level
that would be achieved by complying with Sec.  391.41(b)(10).
    The physical qualification standard for drivers regarding vision
found in Sec.  391.41(b)(10) states that a person is physically
qualified to drive a CMV if that person has distant visual acuity of at
least 20/40 (Snellen) in each eye without corrective lenses or visual
acuity separately corrected to 20/40 (Snellen) or better with
corrective lenses, distant binocular acuity of a least 20/40 (Snellen)
in both eyes with or without corrective lenses, field of vision of at
least 70[deg] in the horizontal meridian in each eye, and the ability
to recognize the colors of traffic signals and devices showing red,
green, and amber.

III. Discussion of Comments

    FMCSA received one comment in this proceeding. Charity Colleen
Crouse submitted a comment expressing concern that these exemptions are
being administered to persons other than the individuals listed in this
notice, and may be used for illegal activity.
    FMCSA verifies the identity and vision deficiencies of individuals
through multiple official documents submitted as part of their requests
for an exemption from the vision requirements. Individuals must submit
a certified motor vehicle record issued from their State Driver
Licensing Agency (SDLA) and a copy of a valid CDL or non-CDL license.
They must also submit information from their ophthalmologist or
optometrist related to a recent medical examination, which verifies the
existence and nature of the vision condition. FMCSA finds these steps
sufficient for verifying the identity of individuals requesting an
exemption and applicability of the exemption.

IV. Basis for Exemption Determination

    Under 49 U.S.C. 31136(e) and 31315(b), FMCSA may grant an exemption
from the FMCSRs for no longer than a 5-year period if it finds such
exemption would likely achieve a level of safety that is equivalent to,
or greater than, the level that would be achieved absent such
exemption. The statute also allows the Agency to renew exemptions at
the end of the 5-year period. FMCSA grants medical exemptions from the
FMCSRs for a 2-year period to align with the maximum duration of a
driver's medical certification.
    The Agency's decision regarding these exemption applications is
based on medical reports about the applicants' vision, as well as their
driving records and experience driving with the vision deficiency. The
qualifications, experience, and medical condition of each applicant
were stated and discussed in detail in the June 19, 2019, Federal
Register notice (84 FR 28619) and will not be repeated here.
    FMCSA recognizes that some drivers do not meet the vision
requirement but have adapted their driving to accommodate their
limitation and demonstrated their ability to drive safely. The ten
exemption applicants listed in this notice are in this category. They
are unable to meet the vision requirement in one eye for various
reasons, including amblyopia, enucleation, hyphema, macular ischemia,
retinal detachment, and subluxed lens. In most cases, their eye
conditions did not develop recently. Eight of the applicants were
either born with their vision impairments or have had them since
childhood. The two individuals that developed their vision conditions
as adults have had them for a range of four to six years. Although each
applicant has one eye that does not meet the vision requirement in
Sec.  391.41(b)(10), each has at least 20/40 corrected vision in the
other eye, and, in a doctor's opinion, has sufficient vision to perform
all the tasks necessary to operate a CMV.
    Doctors' opinions are supported by the applicants' possession of a
valid license to operate a CMV. By meeting State licensing
requirements, the applicants demonstrated their ability to operate a
CMV with their limited vision in intrastate commerce, even though their
vision disqualified them from driving in interstate commerce. We
believe that the applicants' intrastate driving experience and history
provide an adequate basis for predicting their ability to drive safely
in interstate commerce. Intrastate driving, like interstate operations,
involves substantial driving on highways on the interstate system and
on other roads built to interstate standards. Moreover,

driving in congested urban areas exposes the driver to more pedestrian
and vehicular traffic than exists on interstate highways. Faster
reaction to traffic and traffic signals is generally required because
distances between them are more compact. These conditions tax visual
capacity and driver response just as intensely as interstate driving
conditions.
    The applicants in this notice have driven CMVs with their limited
vision in careers ranging for 4 to 84 years. In the past three years,
no drivers were involved in crashes, and one driver was convicted of a
moving violation in CMVs. All the applicants achieved a record of
safety while driving with their vision impairment that demonstrates the
likelihood that they have adapted their driving skills to accommodate
their condition. As the applicants' ample driving histories with their
vision deficiencies are good predictors of future performance, FMCSA
concludes their ability to drive safely can be projected into the
future.
    Consequently, FMCSA finds that in each case exempting these
applicants from the vision requirement in Sec.  391.41(b)(10) is likely
to achieve a level of safety equal to that existing without the
exemption.

V. Conditions and Requirements

    The terms and conditions of the exemption are provided to the
applicants in the exemption document and includes the following: (1)
Each driver must be physically examined every year (a) by an
ophthalmologist or optometrist who attests that the vision in the
better eye continues to meet the standard in Sec.  391.41(b)(10) and
(b) by a certified medical examiner (ME) who attests that the
individual is otherwise physically qualified under Sec.  391.41; (2)
each driver must provide a copy of the ophthalmologist's or
optometrist's report to the ME at the time of the annual medical
examination; and (3) each driver must provide a copy of the annual
medical certification to the employer for retention in the driver's
qualification file, or keep a copy in his/her driver's qualification
file if he/she is self-employed. The driver must also have a copy of
the exemption when driving, for presentation to a duly authorized
Federal, State, or local enforcement official.

VI. Preemption

    During the period the exemption is in effect, no State shall
enforce any law or regulation that conflicts with this exemption with
respect to a person operating under the exemption.

VII. Conclusion

    Based upon its evaluation of the ten exemption applications, FMCSA
exempts the following drivers from the vision requirement, Sec.
391.41(b)(10), subject to the requirements cited above:

Joseph A. Cardazone (NJ)
Daniel R. Cope, Sr. (IA)
Timothy E. Coultas (IL)
Edwin Figueroa (IL)
Robert F. LaMark (PA)
Con May (IN)
Justin E. Schwada (MO)
Jeffrey A. Sherman (OH)
Chadwick L. St. John (AL)
Clinton A. Vandervoort (TX)

    In accordance with 49 U.S.C. 31136(e) and 31315(b), each exemption
will be valid for 2 years from the effective date unless revoked
earlier by FMCSA. The exemption will be revoked if the following
occurs: (1) The person fails to comply with the terms and conditions of
the exemption; (2) the exemption has resulted in a lower level of
safety than was maintained prior to being granted; or (3) continuation
of the exemption would not be consistent with the goals and objectives
of 49 U.S.C. 31136(e) and 31315(b).

    Issued on: August 29, 2019.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2019-19261 Filed 9-5-19; 8:45 am]
 BILLING CODE 4910-EX-P


[Federal Register Volume 83, Number 112 (Monday, June 11, 2018)]
[Notices]
[Page 27055]
[FR Doc No: 2018-12431]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-83383; File No. SR-NASDAQ-2017-087]

Self-Regulatory Organizations; The NASDAQ Stock Market LLC;
Notice of Withdrawal of Proposed Rule Change To Modify the Listing
Requirements Related to Special Purpose Acquisition Companies Listing
Standards To Reduce Round Lot Holders on Nasdaq Capital Market for
Initial Listing From 300 to 150 and Eliminate Public Holders for
Continued Listing From 300 to Zero, Require $5 Million in Net Tangible
Assets for Initial and Continued Listing on Nasdaq Capital Market, and
Impose a Deadline To Demonstrate Compliance With Initial Listing
Requirements on All Nasdaq Markets Within 30 Days Following Each
Business Combination

June 5, 2018.
    On September 20, 2017, The NASDAQ Stock Market LLC (``Nasdaq'' or
``Exchange'') filed with the Securities and Exchange Commission
(``Commission''), pursuant to Section 19(b)(1) of the Securities
Exchange Act of 1934 (``Act'') \1\ and Rule 19b-4 thereunder,\2\ a
proposed rule change to modify the listing requirements for securities
of Special Purpose Acquisition Companies (``SPACs'') listed on the
Nasdaq Capital Market by reducing the number of round lot holders
required for initial listing from 300 to 150, and eliminating the
continued listing requirement for a minimum number of holders, which is
also currently 300, that applies until the SPAC completes one or more
business combinations.\3\ Nasdaq also proposed to require that a SPAC
maintain at least $5 million net tangible assets for initial and
continued listing of its securities on the Nasdaq Capital Market.
Finally, Nasdaq proposed to allow SPACs listed on any of its three
listing tiers (Nasdaq Global Select Market, Nasdaq Global Market, and
Nasdaq Capital Market) 30 days to demonstrate compliance with initial
listing requirements following each business combination.\4\
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ See Nasdaq Rule IM-5101-2(b).
    \4\ The Exchange also proposed to delete a duplicative paragraph
from the rule text and alter the paragraph's formatting within
certain provisions in order to enhance the rule's readability.
---------------------------------------------------------------------------

    The proposed rule change was published for comment in the Federal
Register on October 11, 2017.\5\ In response, the Commission received
six comments on the proposal.\6\ On November 22, 2017, the Commission
extended the time period within which to approve the proposed rule
change, disapprove the proposed rule change, or institute proceedings
to determine whether to approve or disapprove the proposed rule change,
to January 9, 2018.\7\ On January 9, 2018, the Commission issued an
order instituting proceedings under Section 19(b)(2)(B) of the Act to
determine whether to approve or disapprove the proposed rule change
(``OIP'').\8\ The Commission received three additional comments, one of
which included a response from Nasdaq.\9\ On April 6, 2018, the
Commission designated a longer period for the Commission to issue an
order approving or disapproving the proposed rule change.\10\ On June
1, 2018, the Exchange withdrew the proposed rule change (SR-NASDAQ-
2017-087).
---------------------------------------------------------------------------

    \5\ See Securities Exchange Act Release No. 81816 (October 4,
2017), 82 FR 47269 (October 11, 2017) (``Notice'').
    \6\ See Letters to Brent J. Fields, Secretary, Commission, from
Jeffrey M. Solomon, Chief Executive Officer, Cowen and Company, LLC,
dated October 19, 2017 (``Cowen Letter''); Jeffrey P. Mahoney,
General Counsel, Council of Institutional Investors, dated October
25, 2017 (``CII Letter''); Sean Davy, Managing Director, Capital
Markets Division, SIFMA, dated October 31, 2017 (``SIFMA Letter'');
Akin Gump Strauss Hauer & Feld LLP, dated November 1, 2017 (``Akin
Gump Letter''); Steven Levine, Chief Executive Officer,
EarlyBirdCapital, Inc., dated November 3, 2017 (``EarlyBird
Letter''); and Christian O. Nagler and David A. Curtiss, Kirkland &
Ellis LLP, dated November 9, 2017 (``Kirkland Letter'').
    \7\ See Securities Exchange Act Release No. 82142 (November 22,
2017), 82 FR 56293 (November 28, 2017).
    \8\ See Securities Exchange Act Release No. 82478 (January 9,
2018), 83 FR 2278 (January 16, 2018).
    \9\ See Letters to Brent J. Fields, Secretary, Commission, from
Jeffrey P. Mahoney, General Counsel, Council of Institutional
Investors, dated January 25, 2018 (``CII Letter II''); Paul D.
Tropp, Freshfields Bruckhaus Deringer US LLP, dated January 30, 2018
(``Freshfields Letter''); and Arnold Golub, Deputy General Counsel,
Nasdaq, dated February 23, 2018 (``Nasdaq Response Letter'' or
``Response Letter'').
    \10\ See Securities Exchange Act Release No. 83010 (April 6,
2018), 83 FR 15880 (April 12, 2018).

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\11\
---------------------------------------------------------------------------

    \11\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Eduardo A. Aleman,
Assistant Secretary.
[FR Doc. 2018-12431 Filed 6-8-18; 8:45 am]
 BILLING CODE 8011-01-P


[Federal Register: September 20, 2010 (Volume 75, Number 181)]
[Notices]
[Page 57279-57280]
[DOCID:fr20se10-55]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]

Risk Communication Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
    Name of Committee: Risk Communication Advisory Committee.
    General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.

    Date and Time: The meeting will be held on November 8, 2010, from 8
a.m. to 5 p.m. and November 9, 2010, from 8 a.m. to 2 p.m.
    Location: FDA White Oak Campus, Building 31 Conference Center,
Great Room, 10903 New Hampshire Ave., Silver Spring, MD 20993. Please
note visitors can park in the southwest garage near Building 31 or the
northwest parking lot near Building 22 (for a campus map, see http://
www.fda.gov/downloads/AboutFDA/WorkingatFDA/BuildingsandFacilities/
WhiteOakCampusInformation/UCM194893.pdf). Visitors to the White Oak
Campus must have a valid driver's license or other picture ID, and must
enter through Building 1.
    Contact Person: Lee L. Zwanziger, Office of Policy, Planning and
Preparedness, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 32, rm. 3278, Silver Spring, MD, 20993,<PHONE_NUMBER>, FAX: 301-
847-8611, e-mail<EMAIL_ADDRESS>or FDA Advisory Committee
Information Line, 1-800-741-8138<PHONE_NUMBER> in the Washington, DC
area), code<PHONE_NUMBER>. Please call the Information Line for up-to-date
information on this meeting. A notice in the Federal Register about
last minute modifications that impact a previously announced advisory
committee meeting cannot always be published quickly enough to provide
timely notice. Therefore, you should always check the agency's Web site
and call the appropriate advisory committee hot line/phone line to
learn about possible modifications before coming to the meeting.
    Agenda: On November 8 and 9, 2010, the Committee will hear and
discuss developments in FDA's ongoing communications programs, such as
FDA's Strategic Plan for Risk Communication, FDA's Transparency
Initiative, and the challenges of effectively communicating with
patients and caregivers about appropriate use of medical devices when a
patient is prescribed a medical device for home use.
    FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its Web site prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's Web site after the meeting. Background material is
available at http://www.fda.gov/AdvisoryCommittees/Calendar/
default.htm. Scroll down to the appropriate advisory committee link.
    Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before
October 29, 2010. Oral presentations from the public will be scheduled
between approximately 1 p.m. and 2 p.m. on November 8, 2010, and 10:30
to 11:30 a.m. on November 9, 2010. Those desiring to make formal oral
presentations should notify the contact person and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their presentation
on or before October 21, 2010. Time allotted for each presentation may
be limited. If the number of registrants requesting to speak is greater
than can be reasonably accommodated during the scheduled open public
hearing session, FDA may conduct a lottery to determine the speakers
for the scheduled open public hearing session. The contact person will
notify interested persons regarding their request to speak by October
22, 2010.
    Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
    FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Lee Zwanziger at
least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our Web site at http://www.fda.gov/
AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures
on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: September 14, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-23368 Filed 9-17-10; 8:45 am]
BILLING CODE 4160-01-S


[Federal Register: September 10, 2007 (Volume 72, Number 174)]
[Notices]
[Page 51693-51695]
[DOCID:fr10se07-90]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-56348; File No. SR-NASDAQ-2007-073]

Self-Regulatory Organizations; The NASDAQ Stock Market LLC;
Notice of Filing and Immediate Effectiveness of Proposed Rule Change to
Modify the Halt Cross Process

August 31, 2007.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on August 20, 2007, The NASDAQ Stock Market LLC (``Nasdaq''), filed
with the Securities and Exchange Commission (``Commission'') the
proposed rule change as described in Items I and II below, which Items
have been substantially prepared by Nasdaq. On August 31, 2007, the
Exchange filed Amendment No. 1 to the proposed rule change.\3\ The
Exchange filed the proposal as a ``non-controversial'' proposed rule
change pursuant to Section 19(b)(3)(A) of the Act \4\ and Rule 19b-
4(f)(6) thereunder,\5\ which rendered the proposal effective upon
filing with the Commission. The Commission is publishing this notice to
solicit comments on the proposed rule change, as amended, from
interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ Amendment No. 1 replaced the original filing in its
entirety.
    \4\ 15 U.S.C. 78s(b)(3)(A).
    \5\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    Nasdaq proposes to make minor modifications to the manner in which
Nasdaq resumes trading of securities that are the subject of the Nasdaq
Halt Cross as well as the potential duration of the Display Only
Period, as set forth in Nasdaq Rule 4120. The text of the proposed rule
change is available at Nasdaq, the Commission's Public Reference Room,
and http://www.complinet.com/nasdaq.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, Nasdaq included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. Nasdaq has prepared summaries, set forth in Sections A,
B, and C below, of the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    Nasdaq's Halt Cross has been in production for one year and in that
time it has proven to be a highly successful process to begin trading
Nasdaq-listed securities. With the transition of Nasdaq-listed trading
to a single platform in October 2006, Nasdaq implemented a similar
process for resuming trading in halted stocks referred to as the Halt
cross, providing greater transparency as issues begin trading again
after a halt.
    NASDAQ has determined that by amending certain rules governing the
Halt Cross, NASDAQ can provide more accurate price discovery to market
participants. First, Nasdaq is proposing to extend the period of time
those securities may be subject to Display Only status prior to the
operation of the Halt Cross. Currently, after the initial 15-minute
Display Only period, Nasdaq may extend the Display Only period for up
to three additional 5-minute intervals, for a total of 15 additional
minutes. Nasdaq believes that the price discovery capability of the
Halt Cross will be improved by permitting additional Display Only
periods. Therefore, Nasdaq is proposing to authorize up to three
additional 5-minute extensions of the Display Only Period for a total
of 30 minutes. This proposal will not alter how Nasdaq extends the
Display Only period or how Nasdaq operates the Halt Cross.
    Second, Nasdaq is proposing to change the existing mechanism for
extending the duration of the ``Display Only'' period that occurs prior
to the Halt Cross during which time members enter quotes and orders
they expect to participate in the Halt Cross. The current rule states
that the Display Only period for Halt Crosses will be extended by 5
minutes in the event that the Current Reference Price moves more than
10% between the imbalance dissemination 15 seconds prior to the cross
and the cross time. Nasdaq has reviewed data from Halt Crosses and
found that the 10% threshold is wider than necessary. For example, in
reviewing a series of 13 IPOs from the beginning of 2007, 1 moved 4% in
the last 15 seconds, 1 moved 1.5%, while 11 did not move at all.
Therefore Nasdaq

proposes to tighten the systematic trigger to 5% from the current 10%.
    Finally, Nasdaq also proposes to change the provision of the rule
dealing with the re-opening timeline for the Halt Cross. Currently, the
Halt Cross initiates in a ``randomization'' period of between 0 and 15
seconds after the Display Only period. The randomization period was
designed to deter market participants from timing their participation
in a way that harmed other participants. This provision, however,
occasionally results in other markets trading after the issue has re-
opened but prior to Nasdaq restarting trading using the Halt Cross.
Nasdaq Staff believe that it is potentially disruptive for Nasdaq, as
the listing market and venue for the majority of electronic trading, to
continue a halt after other market centers have resumed trading and,
therefore proposes to eliminate the random period prior to the
execution of the Halt Cross.
2. Statutory Basis
    Nasdaq believes that the proposed rule change is consistent with
the provisions of Section 6 of the Act,\6\ in general and with Section
6(b)(5) of the Act,\7\ in particular, in that it is designed to promote
just and equitable principles of trade, to foster cooperation and
coordination with persons engaged in regulating, clearing, settling,
processing information with respect to, and facilitating transactions
in securities, to remove impediments to and perfect the mechanism of a
free and open market and a national market system and, in general, to
protect investors and the public interest. The proposal will promote
orderly trading with respect to IPOs and re-openings of halted stocks.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78f.
    \7\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    Nasdaq does not believe that the proposed rule change will result
in any burden on competition that is not necessary or appropriate in
furtherance of the purposes of the Act, as amended.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    Written comments were neither solicited nor received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The proposed rule change has become effective pursuant to Section
19(b)(3)(A) of the Act \8\ and Rule 19b-4(f)(6) thereunder \9\ because
it: (i) Does not significantly affect the protection of investors or
the public interest; (ii) does not impose any significant burden on
competition; and (iii) by its terms, does not become operative for 30
days from the date on which it was filed, or such shorter time as the
Commission may designate if consistent with the protection of investors
and the public interest.\10\
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78s(b)(3)(A).
    \9\ 17 CFR 240.19b-4(f)(6).
    \10\ For purposes of calculating the 60-day period within which
the Commission may summarily abrogate the proposed rule change under
Section 19(b)(3)(C) of the Act, the Commission considers the period
to commence on August 31, 2007, the date on which the Exchange
submitted Amendment No. 1. See 15 U.S.C. 78s(b)(3)(C).
---------------------------------------------------------------------------

    A proposed rule change filed under Rule 19b-4(f)(6) normally may
not become operative prior to 30 days after the date of the filing.\11\
However, Rule 19b-4(f)(6)(iii) permits the Commission to designate a
shorter time if such action is consistent with the protection of
investors and the public interest.\12\ The Exchange has requested that
the Commission waive the 30-day operative delay. In support of this
request, Nasdaq has represented that the ``randomization'' period of
between 0 and 15 seconds prior to the execution of the cross currently
provided for in Rule 4120 has led to confusion in the marketplace
because it causes Nasdaq, the listing market, to remain in a halted
state after other trading venues resume trading. Nasdaq believes that
this delay has the potential to promote ``gaming'' behavior by some
market participants that is harmful to other market participants and
also to investors.
---------------------------------------------------------------------------

    \11\ 17 CFR 240.19b-4(f)(6)(iii). In addition, Rule 19b-
4(f)(6)(iii) requires the self-regulatory organization to give the
Commission notice of its intent to file the proposed rule change,
along with a brief description and text of the proposed rule change,
at least five business days prior to the date of filing of the
proposed rule change, or such shorter time as designated by the
Commission. Nasdaq has complied with this requirement.
    \12\ 17 CFR 240.19b-4(f)(6)(iii).
---------------------------------------------------------------------------

    The Commission believes that waiving the 30-day operative delay is
consistent with the protection of investors and the public interest
because it believes that the proposed modifications to the operation of
Nasdaq's Halt Cross should have a positive impact market quality and
enhance the orderliness of trading by removing a potential method for
gaming the re-opening following the Halt Cross. Accordingly, the
Commission designates the proposal to be effective and operative upon
filing with the Commission.\13\
---------------------------------------------------------------------------

    \13\ For purposes only of waiving the 30-day operative delay,
the Commission has considered the proposed rule's impact on
efficiency, competition, and capital formation. 15 U.S.C. 78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of a rule change pursuant
to Section 19(b)(3)(A) of the Act,\14\ the Commission may summarily
abrogate the rule change if it appears to the Commission that such
action is necessary or appropriate in the public interest, for the
protection of investors, or otherwise in furtherance of the purposes of
the Act.
---------------------------------------------------------------------------

    \14\ 15 U.S.C. 78s(b)(3)(A).
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change, as amended, is consistent with the Act. Comments may be
submitted by any of the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml.
); or     Send an e-mail to<EMAIL_ADDRESS>Please include

File Number SR-NASDAQ-2007-073 on the subject line.

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, Station Place, 100 F
Street, NE., Washington, DC 20549-1090.
    All submissions should refer to File Number SR-NASDAQ-2007-073.
This file number should be included on the subject line if e-mail is
used. To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml
). Copies of the submission, all subsequent amendments,

all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for inspection
and copying in the Commission's Public Reference Room, 100 F Street,
NE., Washington, DC 20549, on official business days between the hours
of 10 a.m. and 3 p.m. Copies of such filing also will be

available for inspection and copying at the principal office of the
Nasdaq. All comments received will be posted without change; the
Commission does not edit personal identifying information from
submissions. You should submit only information that you wish to make
available publicly. All submissions should refer to File Number SR-
NASDAQ-2007-073 and should be submitted on or before October 1, 2007.

    For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\15\
---------------------------------------------------------------------------

    \15\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Florence E. Harmon,
Deputy Secretary.
[FR Doc. E7-17720 Filed 9-7-07; 8:45 am]

BILLING CODE 8010-01-P


[Federal Register Volume 82, Number 30 (Wednesday, February 15, 2017)]
[Notices]
[Pages 10766-10767]
[FR Doc No: 2017-03067]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OW-2016-0751; FRL-9959-31-OW]

Extension of Public Comment Period: Draft Human Health
Recreational Ambient Water Quality Criteria and/or Swimming Advisories
for Microcystins and Cylindrospermopsin

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is extending the
comment period for the Draft Human Health Recreational Ambient Water
Quality Criteria and/or Swimming Advisories for Microcystins and
Cylindrospermopsin. In response to stakeholder requests, the comment
period will be extended for an additional 31 days, from February 17,
2017 to March 20, 2017.

DATES: Comments must be received on or before March 20, 2017.

ADDRESSES: Submit your comments, identified by Docket ID No. EPA-HQ-OW-
2016-0751, to the Federal eRulemaking Portal: http://www.regulations.gov. Follow the online instructions for submitting
comments. Once submitted, comments cannot be edited or withdrawn. EPA
may publish any comment received to its public docket. Do not submit
electronically any information you consider to be Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute. Multimedia submissions (audio, video, etc.) must be
accompanied by a written comment. The written comment is considered the
official comment and should include discussion of all points you wish
to make. EPA will generally not consider comments or comment contents
located outside of the primary submission (i.e., on the web, cloud, or
other file sharing system). For additional submission methods, the full
EPA public comment policy, information about CBI or multimedia
submissions, and general guidance on making effective comments, please
visit http://www2.epa.gov/dockets/commenting-epa-dockets.

FOR FURTHER INFORMATION CONTACT: John Ravenscroft, Health and
Ecological Criteria Division, Office of Water (Mail Code 4304T),
Environmental Protection Agency, 1200 Pennsylvania Avenue NW.,
Washington, DC 20460; telephone number:<PHONE_NUMBER>; email address:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: On December 19, 2016 (81 FR 91929), EPA
announced the availability of the Draft Human Health Recreational
Ambient Water Quality Criteria and/or Swimming Advisories for
Microcystins and Cylindrospermopsin, and opened a 60-day public review
and comment period. During the comment period, EPA is soliciting
additional scientific views, data, and information regarding the
science and technical approach used in the derivation of the draft
Human Health Recreational Ambient Water Quality Criteria and/or
Swimming Advisories for Microcystins and Cylindrospermopsin document.
EPA is proposing that these recommended criteria, if adopted by States
or authorized Tribes as CWA section 303(c) WQS, be used for CWA section
303(d) assessment and listing purposes where the magnitude is not
exceeded for more than 10 percent of days during a recreational season
up to one calendar year as an indicator of long-term impairment from
multiple short-term blooms. EPA is soliciting public comment on this 10
percent exceedance

frequency as well as alternative exceedance frequencies. For swimming
advisories, EPA is proposing that these recommended values could be
used to trigger public notification whenever values are exceeded for
one day. EPA is soliciting public comment on this recommended single
day exceedance as well as alternative exceedance frequencies.
    The original deadline to submit comments was February 17, 2017.
This action extends the comment period for 31 days, for a total of 91
days of public comment. Written comments must now be received by March
20, 2017. The draft report and other supporting materials may also be
viewed and downloaded from EPA's Web site at https://www.epa.gov/wqc/microbial-pathogenrecreational-water-quality-criteria#swimming.

    Dated: February 2, 2017.
Michael Shapiro,
Acting Assistant Administrator, Office of Water.
[FR Doc. 2017-03067 Filed 2-14-17; 8:45 am]
 BILLING CODE 6560-50-P